Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-13

Clinical Trial Update: Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating metronomic chemotherapy for metastatic osteosarcoma, with the current status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Grupo de Apoio ao Adolescente e a Crianca com Cancer | Conditions: Osteosarcoma | Phase 2 | Status: UNKNOWN